US Patent Issued to Xact Laboratories on Dec. 2 for "System and method for alerting providers to ineffective or under effective treatments based on genetic efficacy testing results" (Ohio, Pennsylvania Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,488,882, issued on Dec. 2, was assigned to Xact Laboratories LLC (Twinsburg, Ohio).

"System and method for alerting providers to ineffective or under effective treatments based on genetic efficacy testing results" was invented by Rob Todd (Doylestown, Pa.), Jerry Wrobel (Aurora, Ohio) and John Pigott (Slyvania, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "System and methods for alerting a healthcare provider to prescribed treatments having reduced or no effectiveness due to genetic composition is provided. A database containing treatments known to have reduced or no efficacy in persons having particular genetic markers is queried to determine whet...